Alex Slanix Paul — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Alex Slanix Paul has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
According to the most recent SEC filing dated May 22, 2026, Alex Slanix Paul serves as a director of ProMIS Neurosciences Inc., a biotechnology company focused on neurodegenerative disease research. Public information available from the filing indicates his board membership, but there is limited publicly disclosed background information beyond this governance role. As of the filing date, he is an active director of the company.
Role
Director
Notability
45/100
Board memberships
ProMIS Neurosciences Inc.
Awards & honors
Board director, ProMIS Neurosciences Inc., as of 2026-05-22
According to the most recent SEC filing dated May 22, 2026, Alex Slanix Paul serves as a director of ProMIS Neurosciences Inc., a biotechnology company focused on neurodegenerative disease research. Public information available from the filing indicates his board membership, but there is limited publicly disclosed background information beyond this governance role. As of the fi…
How many SEC Form 4 filings has Alex Slanix Paul submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Alex Slanix Paul's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
